ES2478692B1 - Formulaciones líquidas de carbocisteína de propiedades mejoradas - Google Patents

Formulaciones líquidas de carbocisteína de propiedades mejoradas Download PDF

Info

Publication number
ES2478692B1
ES2478692B1 ES201201252A ES201201252A ES2478692B1 ES 2478692 B1 ES2478692 B1 ES 2478692B1 ES 201201252 A ES201201252 A ES 201201252A ES 201201252 A ES201201252 A ES 201201252A ES 2478692 B1 ES2478692 B1 ES 2478692B1
Authority
ES
Spain
Prior art keywords
carbocysteine
formulations
liquid
improved properties
improved stability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES201201252A
Other languages
English (en)
Other versions
ES2478692A1 (es
Inventor
Elena PÉREZ HERNANDO
Silvia Jezabel RAMÍREZ UÑA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ITF Research Pharma SL
Original Assignee
ITF Research Pharma SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50977649&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2478692(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ITF Research Pharma SL filed Critical ITF Research Pharma SL
Priority to ES201201252A priority Critical patent/ES2478692B1/es
Priority to PCT/ES2013/070904 priority patent/WO2014096497A1/es
Publication of ES2478692A1 publication Critical patent/ES2478692A1/es
Application granted granted Critical
Publication of ES2478692B1 publication Critical patent/ES2478692B1/es
Priority to CL2015001729A priority patent/CL2015001729A1/es
Priority to MA38255A priority patent/MA38255A1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/12Mucolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Formulaciones líquidas de carbocisteína de estabilidad y cualidades organolépticas mejoradas.

Description



imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8

Claims (1)



  1. imagen1
    imagen2
ES201201252A 2012-12-19 2012-12-19 Formulaciones líquidas de carbocisteína de propiedades mejoradas Active ES2478692B1 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES201201252A ES2478692B1 (es) 2012-12-19 2012-12-19 Formulaciones líquidas de carbocisteína de propiedades mejoradas
PCT/ES2013/070904 WO2014096497A1 (es) 2012-12-19 2013-12-19 Formulaciones líquidas de carbocisteína de propiedades mejoradas
CL2015001729A CL2015001729A1 (es) 2012-12-19 2015-06-18 Formulaciones líquidas que comprenden carbocisteína, al menos un agente regulador de ph, al menos un edulcorante y al menos un disolvente; y su uso para el tratamiento o la prevención de enfermedades del tracto respiratorio caracterizadas por producción de mucosidad excesiva y/o viscosa tales como gripe, otitis, epoc, bronquitis asmática y fibrosis quística.
MA38255A MA38255A1 (fr) 2012-12-19 2015-07-09 Préparations liquides de carbocistéine à propriétés améliorées

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201201252A ES2478692B1 (es) 2012-12-19 2012-12-19 Formulaciones líquidas de carbocisteína de propiedades mejoradas

Publications (2)

Publication Number Publication Date
ES2478692A1 ES2478692A1 (es) 2014-07-22
ES2478692B1 true ES2478692B1 (es) 2015-04-29

Family

ID=50977649

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201201252A Active ES2478692B1 (es) 2012-12-19 2012-12-19 Formulaciones líquidas de carbocisteína de propiedades mejoradas

Country Status (4)

Country Link
CL (1) CL2015001729A1 (es)
ES (1) ES2478692B1 (es)
MA (1) MA38255A1 (es)
WO (1) WO2014096497A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1009513B (el) * 2017-10-05 2019-04-24 Laboserve Φαρμακευτικη Βιομηχανια Α.Ε. Ποσιμα φαρμακευτικα διαλυματα που περιλαμβανουν καρβοκυστεϊνη
CN112438947B (zh) * 2019-09-04 2022-08-26 武汉武药科技有限公司 羧甲司坦口服溶液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0813737B2 (ja) * 1986-12-19 1996-02-14 杏林製薬株式会社 シロツプ剤
WO2002041887A1 (fr) * 2000-11-21 2002-05-30 Kyorin Pharmaceutical Co., Ltd. Preparations seches de sirop

Also Published As

Publication number Publication date
MA38255A1 (fr) 2016-11-30
CL2015001729A1 (es) 2015-09-11
ES2478692A1 (es) 2014-07-22
WO2014096497A1 (es) 2014-06-26

Similar Documents

Publication Publication Date Title
ES2644822T3 (es) Carrete de cordón retráctil
ES2644844T3 (es) Mecanismo de soporte
ES2643814T3 (es) Carretilla elevadora equipada con medios de estabilización
ES2642212T3 (es) Cierre de cremallera
JP2014520786A5 (es)
ES2478692B1 (es) Formulaciones líquidas de carbocisteína de propiedades mejoradas
JP2013217224A5 (es)
JP2014205658A5 (es)
Koch Finding free will
ES2642712T3 (es) Péptidos de foenixina
ES2644814T3 (es) Montaje de rodillo de alimentación
ES2641926T3 (es) Preparado alimenticio
ES2644697T3 (es) Caracterización óptica de ADN y/o ARN
City City GML
FR2997784B1 (fr) Codage d'une image
SUKEL LUST'S Reward
Suci Analysis Of Illocutionary Act In The Prince And The Pauper Movie
김주성 et al. The Little Prince & VTS/VTSOs
부록 The Journal of Saramdaum Education
Kianpour Director's Note
Dubcová Present Challenges of the International Business Ethics
UA28804S (uk) Двосторонній дерев'яний сувенір-магніт
FR2985896B3 (fr) La couette
ES1077117Y (es) Manta o edredón combinados.
UA28805S (uk) Двосторонній дерев'яний сувенір-ікона

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2478692

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20150429